NCT02486185

Brief Summary

Background to the research: Sarcopenia is a geriatric syndrome defined by progressive generalised loss of skeletal muscle, mass, force and function. Problem statement and objectives: To validate a simple, reproducible, screening tool, which is easy to use in the general practitioner's surgery is one of the challenges of the future. The primary objective is to assess the sensitivity and specificity of the study screening test, the SARC-F, at a predetermined threshold of \>= 4. A total score of \>=4 is associated with poor physical performance and is also predictive of the clinical diagnosis of the disease. The secondary objectives are to assess the prevalence of sarcopenia in the study population, to carry out a subgroup analysis of statistical performance for the five questions tested by the SARC-F, to identify the main risk factors associated with the disease and to propose an algorithm, positioning the SARC-F at the heart of a systematic screening process for the disease. Materials and methods: This is a diagnostic, cross-sectional study with a descriptive and analytical epidemiological component to analyse the secondary endpoints. It will be carried out in usual care over a period of 6 months in a homogeneous population of 65-year-old and older patients from the community consulting in primary care. The subjects will undergo the screening test (SARC-F questionnaire) and then the reference clinical assessment (gold standard) in succession. Expected results: To demonstrate the statistical tests that the SARC-F questionnaire is a simple tool, appropriate for early screening of sarcopenia in primary care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
366

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2014

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 16, 2014

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 1, 2015

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 1, 2015

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2016

Completed
Last Updated

February 19, 2018

Status Verified

February 1, 2018

Enrollment Period

1.6 years

First QC Date

April 1, 2015

Last Update Submit

February 15, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • questionnaire SARC-F

    thirty minutes

Secondary Outcomes (1)

  • number of participant

    thirty minutes

Study Arms (1)

SARC-F

OTHER

screening test for sarcopenia being studied, the SARC-F

Other: SCREENING TEST

Interventions

* Skeletal muscle mass, which will be estimated by calculating values for the mid-arm muscle circumference (MAMC) from brachial perimeter (BP) and triceps skinfold thickness (TSF). * Muscle force will be measured using a hydraulic dynamometer * Physical performance will be estimated from the subject's Gait speed using a 4 meter gait test (Gait speed 4-m)

SARC-F

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Men or women who are 65-year old or older consulting a general practitioner, regardless of initial reason for the consultation.
  • Patients agreeing to take part in the study after clear, true and appropriate information has been provided, giving their signed consent and having been given by hand a patient information sheet.

You may not qualify if:

  • Patients with cognitive disorders suffering from major incapacity making understanding the study or signing the informed consent impossible.
  • Patients not affiliated to a Social Security system.
  • Patients suffering from acute functional problems interfering with the tests being performed (incapacity, malformation of the arm, plaster or splint).
  • Patients institutionalised in nursing homes or subacute care
  • Patients who use a technical aid for walking, unless this aid is a walking stick
  • Patients not being followed up in a general practitioner's surgery (absence of information required to carry out the analytical part)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cabinet de Médecine Générale

Cozzano, Corsica, 20148, France

Location

Cabinet de médecine générale

Peri, Corsica, 20167, France

Location

MeSH Terms

Conditions

Sarcopenia

Interventions

Mass Screening

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosisHealth SurveysSurveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesDiagnostic ServicesPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthPublic Health Practice

Study Officials

  • Stéphane M SCHNEIDER

    schneider.s@chu-nice.fr

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2015

First Posted

July 1, 2015

Study Start

November 16, 2014

Primary Completion

June 10, 2016

Study Completion

June 10, 2016

Last Updated

February 19, 2018

Record last verified: 2018-02

Locations